MeSH term
Frequency | Condition_Probility | Child, Preschool | 3 | 0.0 |
Humans | 131 | 0.0 |
DNA-Binding Proteins/*metabolism | 10 | 0.0 |
Macromolecular Substances | 7 | 0.0 |
Protein Binding | 13 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 85 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 59 | 0.0 |
Trans-Activation (Genetics) | 9 | 0.0 |
Transcription Factors/*metabolism | 9 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Cluster Analysis | 2 | 1.0 |
*Gene Expression Profiling | 4 | 0.0 |
*Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Middle Aged | 18 | 0.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Time Factors | 5 | 0.0 |
Adolescent | 3 | 0.0 |
Adult | 13 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Genes, jun | 11 | 14.0 |
Animals | 54 | 0.0 |
Cell Lineage | 2 | 0.0 |
Cells, Cultured | 10 | 0.0 |
*Gene Expression Regulation | 8 | 0.0 |
Models, Biological | 4 | 0.0 |
Signal Transduction | 7 | 0.0 |
*Transcription, Genetic | 7 | 0.0 |
Cell Survival/physiology | 2 | 1.0 |
NF-kappa B/*metabolism | 3 | 0.0 |
Proto-Oncogene Proteins/metabolism | 3 | 0.0 |
Tumor Cells, Cultured | 20 | 0.0 |
Apoptosis | 4 | 0.0 |
Blotting, Western | 6 | 0.0 |
Female | 24 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Male | 21 | 0.0 |
Prognosis | 5 | 0.0 |
Survival Analysis | 3 | 0.0 |
Cell Line | 22 | 0.0 |
Comparative Study | 17 | 0.0 |
DNA/metabolism | 6 | 0.0 |
Proto-Oncogene Proteins c-fos/*metabolism | 5 | 14.0 |
Proto-Oncogene Proteins c-jun/*metabolism | 11 | 14.0 |
Transcription Factor AP-1/*metabolism | 6 | 3.0 |
Cell Division | 3 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Mice | 27 | 0.0 |
Mice, Nude | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 5 | 0.0 |
Transcription Factors/chemistry/*metabolism | 2 | 1.0 |
Aged | 8 | 0.0 |
Phosphorylation | 14 | 0.0 |
Signal Transduction/physiology | 4 | 0.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Transcription Factor AP-1/genetics/*metabolism | 2 | 7.0 |
Carbon-Oxygen Lyases/*metabolism | 2 | 10.0 |
DNA Damage | 2 | 0.0 |
*DNA-(Apurinic or Apyrimidinic Site) Lyase | 2 | 5.0 |
Enzyme Activation | 6 | 0.0 |
K562 Cells | 2 | 0.0 |
Oxidation-Reduction | 6 | 0.0 |
Protein Kinase C/*metabolism | 2 | 0.0 |
Reactive Oxygen Species/*metabolism | 2 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 10 | 0.0 |
Luciferases/genetics | 2 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
*Promoter Regions (Genetics) | 6 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
Sequence Deletion | 2 | 0.0 |
TATA Box | 2 | 0.0 |
Transfection | 22 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
COS Cells | 3 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
Genes, jun/genetics | 2 | 12.0 |
Proto-Oncogene Proteins c-jun/genetics/*metabolism | 7 | 21.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Transcription, Genetic | 13 | 0.0 |
Pregnancy | 3 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Amino Acid Sequence | 24 | 0.0 |
Amino Acid Substitution | 2 | 0.0 |
Base Sequence | 30 | 0.0 |
Binding Sites | 16 | 0.0 |
DNA/chemistry/*metabolism | 2 | 3.0 |
*DNA-Binding Proteins | 3 | 0.0 |
Dimerization | 3 | 0.0 |
Models, Molecular | 4 | 0.0 |
Molecular Sequence Data | 42 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Protein Conformation | 5 | 0.0 |
Protein Structure, Secondary | 4 | 0.0 |
Rats | 11 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 6 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Mutagenesis | 3 | 0.0 |
Proto-Oncogene Proteins c-fos/genetics/*metabolism | 2 | 8.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 12 | 0.0 |
Transcription Factor AP-1/metabolism | 6 | 2.0 |
Transcription, Genetic/*drug effects | 2 | 0.0 |
*Oxidation-Reduction | 2 | 9.0 |
Tetradecanoylphorbol Acetate/*pharmacology | 3 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Disease Models, Animal | 2 | 0.0 |
JNK Mitogen-Activated Protein Kinases | 9 | 1.0 |
Mitogen-Activated Protein Kinases/*metabolism | 5 | 0.0 |
Phenotype | 5 | 0.0 |
Proto-Oncogene Proteins c-jun/metabolism | 11 | 8.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
Free Radical Scavengers/pharmacology | 2 | 3.0 |
Hydrogen Peroxide/pharmacology | 3 | 1.0 |
RNA, Messenger/genetics/metabolism | 6 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Transcription Factor AP-1/*genetics | 3 | 15.0 |
Jurkat Cells | 2 | 0.0 |
Point Mutation | 3 | 0.0 |
Gene Expression Regulation | 8 | 0.0 |
Ultraviolet Rays | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 5 | 0.0 |
Molecular Weight | 2 | 0.0 |
*Nuclear Proteins | 8 | 0.0 |
DNA Mutational Analysis | 7 | 0.0 |
*Phylogeny | 2 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Sequence Homology | 2 | 0.0 |
Variation (Genetics)/*genetics | 2 | 0.0 |
Hela Cells | 6 | 0.0 |
Protein p53/*metabolism | 2 | 0.0 |
Chloramphenicol O-Acetyltransferase/genetics | 2 | 0.0 |
Kinetics | 6 | 0.0 |
Proto-Oncogene Proteins c-jun/genetics | 2 | 5.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
*Genes, fos | 4 | 6.0 |
*Genes, jun | 6 | 13.0 |
Aged, 80 and over | 2 | 0.0 |
Child | 3 | 0.0 |
Collagenases/*genetics | 2 | 11.0 |
NAD(P)H Dehydrogenase (Quinone)/*genetics | 3 | 4.0 |
Proto-Oncogene Proteins c-fos/genetics/metabolism | 3 | 11.0 |
Trans-Activators/genetics/*metabolism | 2 | 0.0 |
Promoter Regions (Genetics) | 13 | 0.0 |
Proto-Oncogene Proteins c-fos/metabolism | 7 | 6.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Transcription Factors/metabolism | 3 | 0.0 |
Cattle | 2 | 0.0 |
DNA-Binding Protein, Cyclic AMP-Responsive/metabolism | 2 | 1.0 |
Genes, fos | 7 | 5.0 |
Oligodeoxyribonucleotides/genetics | 2 | 2.0 |
Genome | 2 | 0.0 |
Takifugu/*genetics | 2 | 13.0 |
Gene Expression/drug effects | 2 | 0.0 |
DNA/*metabolism | 4 | 0.0 |
Mutation | 6 | 0.0 |
Cell Nucleus/metabolism | 6 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Neoplasm Proteins/*analysis | 2 | 0.0 |
Proto-Oncogene Proteins c-fos/analysis | 2 | 16.0 |
Proto-Oncogene Proteins c-jun/analysis | 2 | 22.0 |
Receptor, Epidermal Growth Factor/analysis | 2 | 1.0 |
Drosophila melanogaster/*genetics | 2 | 4.0 |
English Abstract | 2 | 0.0 |
Cyclic AMP/*metabolism | 2 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
*Mitogen-Activated Protein Kinases | 3 | 0.0 |
Consensus Sequence | 2 | 0.0 |
Transcription Factors/biosynthesis/*genetics | 3 | 2.0 |
Infant | 3 | 0.0 |
Infant, Newborn | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 8 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
Chromosomes, Human, Pair 12 | 2 | 1.0 |
DNA | 2 | 0.0 |
Transcription Factors/*genetics/metabolism | 3 | 0.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Escherichia coli/genetics | 4 | 0.0 |
Mitogen-Activated Protein Kinase Kinases/metabolism | 2 | 1.0 |
Genes, myc | 3 | 1.0 |
*Oncogenes | 3 | 0.0 |
Transcription Factors/genetics/*physiology | 2 | 1.0 |
Oligodeoxyribonucleotides | 5 | 0.0 |
Phosphates/metabolism | 2 | 2.0 |
DNA Primers | 4 | 0.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Gene Expression | 6 | 0.0 |
Proto-Oncogene Proteins/*genetics | 3 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Blotting, Northern | 5 | 0.0 |
Cell Division/drug effects | 3 | 0.0 |
Cloning, Molecular | 11 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
DNA-(Apurinic or Apyrimidinic Site) Lyase | 3 | 4.0 |
Deoxyribonuclease IV (Phage T4-Induced) | 2 | 4.0 |
*Chromosome Mapping | 3 | 0.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
Crosses, Genetic | 2 | 0.0 |
*Proto-Oncogenes | 10 | 1.0 |
Receptor, Epidermal Growth Factor/*genetics | 2 | 0.0 |
Genetic Vectors | 4 | 0.0 |
*Immediate-Early Proteins | 3 | 1.0 |
Substrate Specificity | 2 | 0.0 |
Zinc Fingers | 2 | 0.0 |
Cysteine/chemistry | 2 | 1.0 |
*Genes, myc | 3 | 1.0 |
Organ Specificity | 2 | 0.0 |
RNA, Messenger/analysis/*biosynthesis | 2 | 6.0 |
Gene Expression Regulation/*genetics | 2 | 1.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
*Gene Expression | 3 | 0.0 |
Genes, ras | 2 | 0.0 |
In Vitro | 4 | 0.0 |
T-Lymphocytes/*metabolism | 2 | 0.0 |
Restriction Mapping | 3 | 0.0 |
Plasmids | 3 | 0.0 |
Protein Kinase C/metabolism | 2 | 0.0 |
Actins/genetics | 2 | 1.0 |
Oligonucleotide Probes | 2 | 0.0 |
Gene Expression Regulation, Neoplastic/*physiology | 2 | 1.0 |
Genes, jun/*genetics | 2 | 28.0 |
Fibroblasts/metabolism | 2 | 0.0 |
Transcription, Genetic/*physiology | 2 | 1.0 |
Sequence Homology, Nucleic Acid | 6 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
Transcription Factors/*genetics | 7 | 0.0 |
*Mutation | 2 | 0.0 |
Proto-Oncogene Proteins c-fos | 9 | 16.0 |
Proto-Oncogene Proteins c-jun | 12 | 24.0 |
Protein-Tyrosine Kinase/genetics | 6 | 5.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 2 | 1.0 |
Open Reading Frames | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 3 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Models, Genetic | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
